Chardan Healthcare Acquisition Corp. (28)

Browse by Contract Category

Contracts

Loan and Security Agreement dated August 16, 2021 by and among BiomX, Inc., BiomX Ltd., RondinX Ltd. and Hercules Capital, Inc (Filed With SEC on August 16, 2021)
Placement Agency Agreement, among BiomX Inc., Cantor Fitzgerald & Co., and Chardan Capital Markets LLC, dated July 26, 2021 (Filed With SEC on July 26, 2021)
A lease agreement dated September 7, 2020 by and among AFI Assets Ltd., AF SHAR Ltd., WIS, Nova Measuring Systems Ltd. and BiomX Ltd. (translated from Hebrew) (Filed With SEC on March 31, 2021)
Description of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 31, 2021)
Chardan Healthcare Acquisition Corp. 2019 Equity Incentive Plan (Filed With SEC on November 1, 2019)
Exclusive Patent License Agreement, dated April 22, 2019, among BiomX Ltd., Keio University and JSR Corporation (Filed With SEC on November 1, 2019)
Amendment Agreement, dated as of October 11, 2019, by and among Chardan Healthcare Acquisition Corp., CHAC Merger Sub Ltd., and BiomX Ltd (Filed With SEC on October 15, 2019)
Form of Warrant (Filed With SEC on July 26, 2021)
Form of Securities Purchase Agreement, among BiomX Inc. and the Purchasers named therein (Filed With SEC on July 26, 2021)
An addendum to a lease agreement dated from May 25, 2017, dated September 7, 2020 by and among AFI Assets Ltd., AF SHAR Ltd., WIS and BiomX Ltd. (translated from Hebrew) (Filed With SEC on March 31, 2021)
Form of Indemnification Agreement (Filed With SEC on November 12, 2020)
Form of Option Agreement (Israeli Awards) (Filed With SEC on March 26, 2020)
Form of Non-Qualified Stock Option Agreement (U.S. Awards to Executive Officers) (Filed With SEC on March 26, 2020)
Form of Non-Qualified Stock Option Agreement (U.S. Awards to Non-Executives) (Filed With SEC on March 26, 2020)
Waiver Letter to Voting Agreement (Filed With SEC on November 4, 2019)
Voting Agreement dated October 28, 2019 (Filed With SEC on November 1, 2019)
Registration Rights Agreement dated October 28, 2019 (Filed With SEC on November 1, 2019)
Purchase Agreement, dated October 28, 2019, between Cornix LLC and Chardan Healthcare Acquisition Corp (Filed With SEC on November 1, 2019)
Form of Indemnification Agreement with each director and officer (Filed With SEC on November 1, 2019)
Escrow Agreement dated October 28, 2019, among Chardan Healthcare Acquisition Corp., Shareholder Representative Services LLC and Continental Stock Transfer & Trust Company (Filed With SEC on November 1, 2019)
Waiver Agreement, dated October 28, 2019 (Filed With SEC on November 1, 2019)
Share Purchase Agreement, dated November 19, 2017, among BiomX Ltd., RondinX Ltd. and Guy Harmelin, as the Shareholders Representative (Filed With SEC on November 1, 2019)
Exclusive Patent License Agreement, dated December 15, 2017, among BiomX Ltd., Keio University and JSR Corporation, as amended (Filed With SEC on November 1, 2019)
Exclusive Patent License Agreement dated April 25, 2017, between BiomX Ltd. and the Massachusetts Institute of Technology (Filed With SEC on November 1, 2019)
Research and License Agreement, dated June 22, 2015, between BiomX Ltd. and Yeda Research and Development Company Limited, as amended (Filed With SEC on November 1, 2019)
Promissory Note dated October 21, 2019 (Filed With SEC on October 21, 2019)
Amendment Agreement, dated as of October 11, 2019, by and among Chardan Healthcare Acquisition Corp., CHAC Merger Sub Ltd., and BiomX Ltd (Filed With SEC on October 11, 2019)
Merger Agreement, dated as of July 16, 2019, by and among Chardan Healthcare Acquisition Corp., CHAC Merger Sub Ltd. and BiomX Ltd (Filed With SEC on July 17, 2019)